Vimian’s Specialty Pharma segment enjoys a strong global position within veterinary allergy, dermatology, otology and specialised nutrition.

We sell diagnostics and treatments to veterinary clinics and retailers in 60 countries reaching over 20,000 veterinarians without intermediaries. Specialty Pharma includes the four therapeutic areas Allergy, Dermatology, Specialised Nutrition and Specialty Pharmaceuticals.

Within Specialty Pharma, Vimian has more than 40 patent families protecting a portfolio of over 1,000 products produced in seven licensed manufacturing facilities and laboratories as well as through select contract manufacturers.

We pursue R&D and innovation in-house as well as in collaboration with strategic partners. In 2023, we launched 78 new products.